Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% below its 1-year average of 20.00%, near the low end of its 1-year range (0.00%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 20.00%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
20.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 553 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Faeth Therapeutics, Inc.
Market Cap
$689.84M
Operating Margin
0.00%
TTM Avg
20.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$681.83M
Operating Margin
317.06%
TTM Avg
-14996.68%
3Y Avg
-12629.31%
5Y Avg
-15360.40%
Market Cap
$667.58M
Operating Margin
15.26%
TTM Avg
16.07%
3Y Avg
9.54%
5Y Avg
2.83%
Market Cap
$712.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$718.41M
Operating Margin
19.61%
TTM Avg
25.44%
3Y Avg
21.88%
5Y Avg
18.67%
Market Cap
$722.43M
Operating Margin
-4908.21%
TTM Avg
-3903.83%
3Y Avg
-2635.01%
5Y Avg
-1845.37%
Market Cap
$655.02M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
Market Cap
$731.98M
Operating Margin
-123601.69%
TTM Avg
-69568.65%
3Y Avg
-35191.57%
5Y Avg
-23714.64%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | $689.84M | 0.00% | 20.00% | 0.00% | 0.00% |
| Helus Pharma Inc. (HELP)vs › | $681.83M | 317.06% | -14996.68% | -12629.31% | -15360.40% |
| Annexon, Inc. (ANNX)vs › | $674.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| MiMedx Group, Inc. (MDXG)vs › | $667.58M | 15.26% | 16.07% | 9.54% | 2.83% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $712.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $718.41M | 19.61% | 25.44% | 21.88% | 18.67% |
| Anteris Technologies Global Corp. (AVR)vs › | $722.43M | -4908.21% | -3903.83% | -2635.01% | -1845.37% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $655.02M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $731.98M | -123601.69% | -69568.65% | -35191.57% | -23714.64% |
| Aura Biosciences, Inc. (AURA)vs › | $640.62M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
